FDA considers patients the real experts when it comes to their own health condition. Rare disease patient listening sessions are one more way FDA is engaging patients in all of the steps of the discovery and development process for medical products.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2oVH3Fb
No comments:
Post a Comment